PurposeThe present study aimed to determine the reliable imaging features to distinguish atypical hepatocellular carcinoma (HCC) with peripheral rim-like enhancement from intrahepatic mass-forming cholangiocarcinoma (IMCC) on contrast-enhanced magnetic resonance imaging (MRI).MethodsA total of 168 patients (130 male, 57.10 ± 10.53 years) pathological confirmed HCC or IMCC who underwent contrast-enhanced MRI between July 2019 and February 2022 were retrospectively included. Univariate and multivariate logistic regression analyses were used to determine independent differential factors for distinguishing HCC from IMCC, and the model was established. Bootstrap resampling 1000 times was used to verify the model, which was visualized by nomogram...
Background & Aims: Contrast enhanced computed tomography (CT-scan) is a standard of care for the rad...
AIM: Primary aim was to validate the percentage of intrahepatic cholangiocarcinomas (ICC) which have...
PURPOSE To determine MR-imaging features for the differentiation between hepatocellular carcinoma (...
Abstract Background Combined hepatocellular-cholangio...
OBJECTIVE: Incidence of intrahepatic mass-forming cholangiocarcinoma (IMCC) is increasing worldwide,...
PURPOSEWe aimed to gain further insight in magnetic resonance imaging characteristics of mass-formin...
This record contains raw data related to article “Intrahepatic Cholangiocellular Carcinoma With Radi...
Purpose: To explore the potential use of magnetic resonance imaging (MRI) in predicting the outcome ...
OBJECTIVES: To assess whether gadoxetic acid-enhanced MRI could be used as a prognostic factor for i...
PURPOSE: Liver transplant guidelines for diagnosing hepatocellular carcinoma (HCC) do not mandate pa...
Background: The diagnosis of intrahepatic cholangiocellular carcinoma (ICC) remains elusive at imagi...
The purpose of this study was to investigate the efficacy of magnetic resonance imaging (MRI) radiom...
Background: The diagnosis of intrahepatic cholangiocellular carcinoma (ICC) remains elusive at imagi...
PURPOSE: To identify imaging markers that independently predict the post-operative outcome of intrah...
Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma u...
Background & Aims: Contrast enhanced computed tomography (CT-scan) is a standard of care for the rad...
AIM: Primary aim was to validate the percentage of intrahepatic cholangiocarcinomas (ICC) which have...
PURPOSE To determine MR-imaging features for the differentiation between hepatocellular carcinoma (...
Abstract Background Combined hepatocellular-cholangio...
OBJECTIVE: Incidence of intrahepatic mass-forming cholangiocarcinoma (IMCC) is increasing worldwide,...
PURPOSEWe aimed to gain further insight in magnetic resonance imaging characteristics of mass-formin...
This record contains raw data related to article “Intrahepatic Cholangiocellular Carcinoma With Radi...
Purpose: To explore the potential use of magnetic resonance imaging (MRI) in predicting the outcome ...
OBJECTIVES: To assess whether gadoxetic acid-enhanced MRI could be used as a prognostic factor for i...
PURPOSE: Liver transplant guidelines for diagnosing hepatocellular carcinoma (HCC) do not mandate pa...
Background: The diagnosis of intrahepatic cholangiocellular carcinoma (ICC) remains elusive at imagi...
The purpose of this study was to investigate the efficacy of magnetic resonance imaging (MRI) radiom...
Background: The diagnosis of intrahepatic cholangiocellular carcinoma (ICC) remains elusive at imagi...
PURPOSE: To identify imaging markers that independently predict the post-operative outcome of intrah...
Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma u...
Background & Aims: Contrast enhanced computed tomography (CT-scan) is a standard of care for the rad...
AIM: Primary aim was to validate the percentage of intrahepatic cholangiocarcinomas (ICC) which have...
PURPOSE To determine MR-imaging features for the differentiation between hepatocellular carcinoma (...